HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria

Tissue Antigens

Volumn 49, Issue 1, 1997, Pages 23-28

  Garcia, F ^a   Marina, A ^a   Albar, J P ^b   Lopez De Castro J A ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Ankylosing spondylitis; HLA B27; Peptide presentation

Indexed keywords

BACTERIAL PROTEIN; HLA B27 ANTIGEN; PEPTIDE;

ANKYLOSING SPONDYLITIS; ANTIGEN PRESENTATION; ARTHROPATHY; ARTICLE; AUTOIMMUNITY; BACTERIAL ARTHRITIS; GENETIC POLYMORPHISM; HUMAN CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; T LYMPHOCYTE;

EID: 0031024761     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02705.x     Document Type: Article

References (28)

1. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet 1973: 1: 904-7.
2. Burmester GR, Daser A, Kamradt T et al. Immunology of reactive arthritides. Anna Rev Immunol 1995: 13: 229-50.
3. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 1990: 63: 1099-112.
4. Breur-Vriesendorp BS, Dekker Saeys AJ, Ivanyi P. Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules. Ann Rheum Dis 1987: 46: 353-6.
5. Lopez-Larrea C, Sujirachato K, Mehra NK et al. HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens 1995: 45: 169-76.
6. D'Amato M, Fiorillo MT, Carcassi C et al. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Ear J Immunol 1995: 25: 3199-201.
7. Rojo S, Garcia F, Villadangos JA, Lopez de Castro JA. Changes in the repertoire of peptides bound to HLA-B27 subtypes and to site-specific mutants inside and outside pocket B. J Exp Med 1993: 177: 613-20.
8. Lopez D, Garcia Hoyo R, Lopez de Castro JA. Clonal analysis of alloreactive T cell responses against the closely related B*2705 and B*2703 subtypes. Implications for HLA-B27 association to spondyloarthropathy. J Immunol 1994: 152: 5557-71.
9. Benjamin R, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990: 11: 137-42.
10. Hermann E, Yu DT, Meyer zum Buschenfelde KH, Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993: 342: 646-50.
11. Scofield RH, Kurien B, Gross T, Warren WL, Harley JB. HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies. Lancet 1995: 345: 1542-4.
12. Galocha B, Lamas JR, Villadangos JA, Albar JP, Lopez de Castro JA. Binding of peptides naturally presented by HLA-B27 to the differentially disease-associated B*2704 and B*2706 subtypes, and to mutants mimicking their polymorphism. Tissue Antigens 1996: 48: 509-518.
13. Benjamin RJ, Madrigal JA, Parham P. Peptide binding to empty HLA-B27 molecules of viable human cells. Nature 1991: 351: 74-7.
14. Calvo V, Rojo S, Lopez D, Galocha B, Lopez de Castro JA. Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism. J Immunol 1990: 144: 4038-45.
15. Ellis SA, Taylor C, McMichael A. Recognition of HLA-B27 and related antigens by a monoclonal antibody. Hum Immunol 1982: 5: 49-59.
16. Barnstable CJ, Bodmer WF, Brown G et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens. New tools for genetic analysis. Cell 1978: 14: 9-20.
17. Ljunggren HG, Karre K. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J Exp Med 1985: 162: 1745-59.
18. Townsend A, Ohlen C, Bastin J, Ljunggren HG, Foster L, Karre K. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 1989: 340: 443-8.
19. Ljunggren HG, Stam NJ. Ohlen C et al. Empty MHC class I molecules come out in the cold. Nature 1990: 346: 476-80.
20. Villadangos JA, Galocha B, Garcia F, Albar JP, Lopez de Castro JA. Modulation of peptide binding by HLA-B27 polymorphism in pockets A and B, and peptide specificity of B*2703. Eur J Immunol 1995: 25: 2370-7.
21. Ezquerra A, Bragado R, Vega MA, Strominger JL, Woody J, Lopez de Castro JA. Primary structure of papain-solubilized human histocompatibility antigen HLA-B27. Biochemistry 1985: 24: 1733-41.
22. Parham P, Adams EJ, Arnett KL. The origins of HLA-A,B,C polymorphism. Immunol Rev 1995: 143: 141-80.
23. Brooks JM, Murray RJ, Thomas WA, Kurilla MG, Rickinson AB. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. J Exp Med 1993: 178: 879-87.
24. Evavold BD, Sloan-Lancaster J, Wilson KJ, Rothbard JB, Allen PM. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 1995: 2: 655-63.
25. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995: 80: 695-705.
26. Scofield RH, Warren WL, Koelsch G, Harley JB. A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution. Proc Natl Acad Sci U S A 1993: 90: 9330-4.
27. Lopez-Larrea C, Alvarez MV, Dieye A, Housan L, Gonzalez-Roces S. HLA-B27 alleles and susceptibility and resistance to AS. Hum Immunol 1996: 47: 73.
28. MacLean L. HLA-B27 subtypes: implications for the spondyloarthropathies. Ann Rheum Dis 1992: 51: 929-31.